title: Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma.
abstract: Pancreatic adenocarcinoma is an untreatable deadly cancer. The factors involved in its early development remain unknown; which contributes to the absence of biomarkers for early detection of malignancy or at-risk subjects, and the absence of efficacious therapeutic agents. Because zinc changes are implicated in some cancers, we determined if it might be involved in the development of pancreatic adenocarcinoma. With in situ Dithizone and Zinquin staining of normal pancreas and adenocarcinoma tissue sections, we show for the first time, a consistent major loss of zinc in ductal and acinar epithelium in adenocarcinoma compared to the normal epithelium. This decrease in zinc is evident in well-differentiated through poorly-differentiated stages of malignancy. Immunohistochemistry identified ZIP3 as the basilar membrane zinc uptake transporter in normal ductal/acinar epithelium; and that the transporter is absent in adenocarcinoma. In situ Rt-PCR revealed that ZIP3 gene expression is silenced in adenocarcinoma. The ZIP3 down regulation accompanied the loss of zinc in early and progressing malignancy. RREB1 transcription factor was down regulated along with ZIP3; and might be involved in the silencing of ZIP3 expression. Zinc treatment was cytotoxic to malignant Panc1 cells. The combination of concurrent zinc, ZIP3, and RREB-1 changes represent early events in the development of adenocarcinoma; and suggest that zinc might be a tumor suppressor of pancreatic cancer. This report provides the clinical foundation for further mechanistic studies that will provide important insight into pancreatic carcinogenesis, and can lead to the development of effective early biomarkers and effective therapeutic agents for pancreatic cancer.
authors: Department of Oncology and Diagnostic Sciences, The University of Maryland, Baltimore, USA. lcostello@umaryland.edu
authors: Leslie C
authors: LC
authors: Costello
authors: Bernard A
authors: BA
authors: Levy
authors: Mohamed M
authors: MM
authors: Desouki
authors: Jing
authors: J
authors: Zou
authors: Omar
authors: O
authors: Bagasra
authors: Leslie A
authors: LA
authors: Johnson
authors: Nader
authors: N
authors: Hanna
authors: Renty B
authors: RB
authors: Franklin
references: Mol Endocrinol. 2007 Sep;21(9):2056-70
references: 17550981
references: Mol Cancer. 2005 Sep 09;4:32
references: 16153295
references: Int J Cancer. 2001 Apr 1;92(1):49-54
references: 11279605
references: Ann N Y Acad Sci. 2003 Dec;1010:316-20
references: 15033742
references: J Am Coll Nutr. 1987 Feb;6(1):41-6
references: 3584728
references: Cancer Res. 1985 Mar;45(3):1285-90
references: 2982487
references: Mol Cell Biol. 1996 Oct;16(10):5335-45
references: 8816445
references: Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18636-41
references: 18003899
references: Mol Cancer. 2006 May 15;5:17
references: 16700911
references: Clin Cancer Res. 2008 Sep 1;14(17):5376-84
references: 18765529
references: Oncogene. 2007 Nov 1;26(50):7143-52
references: 17496927
references: Biochim Biophys Acta. 2009 Feb;1793(2):273-80
references: 18951928
references: Cancer Cell Int. 2006 Mar 31;6:10
references: 16579854
references: Front Biosci. 2005 Sep 01;10:2230-9
references: 15970489
references: Am J Pathol. 2007 Jul;171(1):263-73
references: 17591971
references: Mol Cancer Res. 2009 Feb;7(2):230-6
references: 19208745
references: Am J Pathol. 1965 Aug;47:325-37
references: 14335773
references: J Immunol. 2009 Dec 1;183(11):6948-59
references: 19890057
references: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references: 19474385
references: J Cell Biochem. 2008 May 1;104(1):202-12
references: 17979179
references: Nat Protoc. 2007;2(11):2782-95
references: 18007614
references: Cancer Lett. 2004 Apr 15;207(1):79-87
references: 15050736
references: Biochem J. 2009 Aug 27;422(3):543-51
references: 19558368
references: Gene. 1997 Aug 22;195(2):267-75
references: 9305772
references: Mol Cancer. 2007 Jun 05;6:37
references: 17550612
references: Gene. 2010 Oct 15;466(1-2):49-55
references: 20627121
references: Prostate. 2002 Sep 1;52(4):311-8
references: 12210492
references: J Nucl Med. 1970 Jun;11(6):260-4
references: 4316187
references: Clin Cancer Res. 2009 Oct 1;15(19):5993-6001
references: 19755388
references: Carcinogenesis. 2006 Oct;27(10):1980-90
references: 16606632
references: Methods. 2010 Dec;52(4):316-21
references: 20705137
references: Arch Biochem Biophys. 2007 Jul 15;463(2):211-7
references: 17400177
references: Prostate. 2008 Jun 15;68(9):994-1006
references: 18386292
references: Clin Cancer Res. 2002 Nov;8(11):3579-83
references: 12429649
references: Mol Urol. 2000 Spring;4(1):31-6
references: 10851304
references: Mol Cancer. 2008 Mar 10;7:25
references: 18331646